Artificial exosomes, preparation method and application thereof

An exosome and artificial technology, applied in the field of medicine, can solve problems such as difficulties in establishing standardized solutions, and achieve the effect of wide application prospects

Pending Publication Date: 2019-11-05
GUANGZHOU MEDICAL UNIV
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented technology allows for more efficient deliveries of different substances than current methods like syringomyelia or liposome injection into cells that are already being studied. It also provides an effective way to study complex biological systems such as tumors with specific gene expression patterns.

Problems solved by technology

This patented technical problem addressed in this patents relates to finding ways to create nano particles made up entirely of naturally occurring substances like proteins, nucleic acids, carbohydrates, lipids, peptides, polysaccharide chains, etc., without having any negative effects upon other parts of our bodies' organs (such as bone marrow).

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Artificial exosomes, preparation method and application thereof
  • Artificial exosomes, preparation method and application thereof
  • Artificial exosomes, preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0077] This example is used to illustrate the extraction of membrane proteins.

[0078] In this experiment, Biyuntian's cell membrane protein and cytoplasmic protein extraction kit was used.

[0079] 1) Preparation of reagents: dissolve and mix membrane protein extraction reagents A and B at room temperature, place on ice immediately after dissolving, take appropriate amount of membrane protein extraction reagents A and B for later use, add PMSF within a few minutes before use, and make The final concentration of PMSF was 1 mM. (Note: PMSF must be added within 2-3 minutes before the extraction reagent A is added to the sample, so as to avoid the rapid failure of PMSF in the aqueous solution);

[0080] 2) Culture the cells at 15cm 2 In the culture bottle, raise to 80-90% density, about 2-5×10 7 Remove the medium, wash three times with pre-cooled PBS, use a cell scraper to remove the cells, blow the cells down with a pipette, add 1mL of PBS, transfer to a 1.5mL EP tube, 4°C, ...

Embodiment 2

[0085] This example is used to illustrate the preparation of PLGA / DOTAP nanoparticles of the present invention, and shows the process of loading drug OCT4 protein and siTrim28 in PLGA.

[0086] Prepared by solvent evaporation and water-in-oil-in-water emulsion.

[0087] 1) The mass ratio of DOTAP to PLGA is 1:25, PLGA particles (100mg) and DOTAP powder (4mg) are dissolved in 1mL of dichloromethane, oil phase (O);

[0088] 2) Dissolve OCT4 protein (0.1mg) and siTrim28 (0.1mg) in 300uL nuclease-free water, water phase (W);

[0089] 3) Add the water phase prepared in step 2) dropwise to the oil phase prepared in step 1), while ultrasonicating for 45s, power 60%, 2s on 1s off, and operate on ice;

[0090] 4) After emulsification, add the emulsion obtained in step 3) dropwise into 7% (W / V) polyvinyl alcohol (PVA) aqueous solution (3mL), while ultrasonicating for 1min, power 60%, 2s on 1s off, in ice operation on;

[0091] 5) Add the double emulsion obtained in step 4) into 1% (W...

Embodiment 3

[0095] This example is used to illustrate the preparation of membrane protein-modified liposome-encapsulated PLGA nanoparticles of the present invention.

[0096] The thin layer evaporation (TLE) method was used.

[0097] 1) Combine 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-distearoyl-glycero-3-phosphocholine (DSPC), 1,2-diole Acyl-glycerol-3-phosphocholine (DOPC) and cholesterol (Cholesterol) were respectively dissolved in analytical pure chloroform: anhydrous methanol mixture (3:1 V / V) according to the molar ratio of 5:1:3:1;

[0098] 2) The solvent of the solution obtained in step 1) was then evaporated by a rotary evaporator to form a thin film. Add different proportions of membrane proteins separated from Example 1 to the PLGA / DOTAP / OCT4 / siTrim28 nanoparticle suspension formed in Example 2 (protein: lipid mass ratio=1:100, 1:200, 1:300, 1 : 400, 1: 500), vortexed to mix, and then added to the round bottom flask to hydrate the membrane to assemble into nano...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The present invention provides an artificial exosome, which comprises: an outer lipid shell composed of a modified or unmodified artificial lipid membrane and a polymer core composed of DOTAP-modifiedPLGA nanospheres, and the invention also provides a preparation method and an application thereof. The artificial exosome of the present invention is suitable for achieving simultaneous delivery of multiple components, which provides a theoretical basis for the development of novel drug delivery systems. The method of the invention has broad application prospects in cancer, hereditary diseases and infectious diseases.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner GUANGZHOU MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap